Volume 11, Number 3—March 2005
Human Metapneumovirus RNA in Encephalitis Patient
Highlight and copy the desired format.
|EID||Schildgen O, Glatzel T, Geikowski T, Scheibner B, Simon A, Bindl L, et al. Human Metapneumovirus RNA in Encephalitis Patient. Emerg Infect Dis. 2005;11(3):467-470. https://dx.doi.org/10.3201/eid1103.040676|
|AMA||Schildgen O, Glatzel T, Geikowski T, et al. Human Metapneumovirus RNA in Encephalitis Patient. Emerging Infectious Diseases. 2005;11(3):467-470. doi:10.3201/eid1103.040676.|
|APA||Schildgen, O., Glatzel, T., Geikowski, T., Scheibner, B., Simon, A., Bindl, L....Matz, B. (2005). Human Metapneumovirus RNA in Encephalitis Patient. Emerging Infectious Diseases, 11(3), 467-470. https://dx.doi.org/10.3201/eid1103.040676.|
We describe a fatal case of encephalitis that might be correlated with primary human metapneumovirus (HMPV) encephalitis. Postmortem HMPV RNA was detected in brain and lung tissue samples from the patient. Furthermore, HMPV RNA was found in culture fluids from cells coincubated with lung tissue.
Human metapneumovirus (HMPV), a new member of the paramyxovirus family closely related to respiratory syncytial virus (RSV), was first described in 2001 (1). Subsequent reports demonstrated that HMPV is distributed worldwide (2–5), causing mild-to-severe acute infections of the nasopharyngeal tract (6,7). Although neurologic symptoms have been described for infections caused by other paramyxoviruses, such as Hendra, Nipah, mumps, and measles (8–12), no such symptoms have been associated with HMPV infection. We describe a child who died from edema caused by encephalitis probably induced or triggered by HMPV.
A 14-month-old boy unresponsive to verbal and tactile stimulation with high fever (temperature 39°C) was admitted to a primary care hospital ≈30 minutes after the onset of generalized febrile convulsions that did not respond to 2 doses of rectal diazepam (5 mg). His weight was 8 kg, all extremities were warm and well perfused, his heart rate was 140 beats per minute (bpm), and oxygen saturation was 93% in ambient air. Initial clinical examination showed no purpuric or petechial lesions, no heart murmurs or pulmonary rales, and no palpable enlargement of the liver or spleen. The boy had been healthy until 2 days earlier, when rhinorrhea, mild pharyngitis, and cough developed without signs of lower respiratory tract involvement. On the day of admission, he vomited once in the morning and than refused to drink. In the afternoon of the same day, a high fever developed, and seizures began, with extension and struggling of all extremities but without opisthotonos. The patient initially turned both eyes upwards but later stared straight ahead with no spontaneous eye movements and fixed pupils of 3 to 4 mm in diameter.
The boy had been born at 34 weeks’ gestational age (weight 2,300 g), and he was treated for a few days with antimicrobial drugs after prolonged rupture of amniotic sac membranes, even though early-onset infection had not been confirmed. His neonatal period was uneventful, with the exception of moderate withdrawal symptoms (irritability, frequent bowel movements) probably due to tobacco use by his mother during pregnancy. The primary pediatrician documented a subtle, generalized muscular hypotension at the age of 9 months but did not consider this finding remarkable enough to investigate further (sonographic examination of the central nervous system showed normal results immediately after birth and 2 weeks later).
Clinical seizure activity subsided ≈2 hours after the intravenous administration of diazepam, clonazepam, phenobarbital, and lorazepam. Blood pressure was stable without high volume infusion or vasosuppressor support, and oxygen saturation (pulse oximetry) was 100% with 2 L of supplemental oxygen. Glasgow coma scale (GCS) was 10 at the end of the seizure. Cerebrospinal fluid (CSF) drawn by lumbar puncture showed no pleocytosis, glucose level of 4.6 mmol/L, and a slightly elevated protein content of 116 mg/dL (normal value <45mg/dL) (Table 1). Although leukocyte count and serum C-reactive protein did not suggest inflammation, empiric antimicrobial chemotherapy with ceftriaxone, ampicillin, gentamicin, and acyclovir was started immediately. An electroencephalogram showed generalized slow waves but no seizure activity.
On the basis of abnormal findings on a magnetic resonance imaging scan (MRI) performed 12 hours after admission (Figure 1A and 1B), attending physicians diagnosed meningoencephalitis of unknown origin. During the next few hours, the GCS of the patient deteriorated to 5. Both pupils were 8 mm in diameter and not reactive to light. The patient was intubated (no gag reflex observed during the procedure) and mechanically ventilated. He was sent to the pediatric intensive care unit of a tertiary-care hospital 24 hours after admission to have an external ventricular drain inserted. Upon arrival, the patient was deeply comatose (GCS 5) without response to painful stimuli; he had rectal temperature of 32°C, arrhythmic heart rate (90 bpm), and a mean arterial pressure of 29 mm Hg.
Corneal reflexes and gag reflex were silent. No spontaneous movements were observed; pupils were 5 mm in diameter and fixed. A chest radiograph excluded a pneumonic infection and confirmed the correct position of the ventilation tube and the central venous catheter tip. After stabilization of vital signs, the patient’s condition did not change. The abnormal findings on a computed (CT) tomography scan are shown in Figure 1C. Intracranial pressure measured after inserting an external ventricular drain and repeatedly afterwards was constantly elevated to 90 cm H2O. Brain tissue extruded locally, and the drain was removed after 2 days. Repeated cultures of blood, urine, CSF, brain tissue, and the tip of the external drainage did not show any bacterial (culture) or viral pathogen (culture and polymerase chain reaction [PCR]) (Table 2). The patient did not exclusively display symptoms typical of measles or mumps, and neither of these viruses could be isolated from brain tissue.
In addition, extensive acute investigations of serum and urine specimens did not confirm any underlying inborn or acquired metabolic illness. A battered-child syndrome was excluded by a normal ophthalmologic examination and radiographs of all extremities; no sign of fresh or old fractures was found. After 10 days of supportive intensive care without clinical improvement, in accordance to the current regulations of German federal law, the child was considered to be dead and extubated after receiving informed consent from his legal guardian. He died shortly thereafter, and an autopsy was performed.
The acute symptoms were managed sufficiently by the primary intensive care team, particularly in terms of oxygenation, and no signs of dehydration were seen at admission. Thus, extensive discussion with the attending intensive care, neurosurgery, neuroradiology, and pediatric neurology team led to the conclusion that the time course of the illness suggested encephalitis as the primary reason for the child’s symptoms and the adverse outcome. Other differential diagnoses of the MRI and CT findings such as postictal edema after a status epilepticus, edema due to prolonged hyperpyrexia and dehydration, or hypoxemia were considered highly improbable.
Tissue specimens from brain, lung, liver, kidney, and heart as well as serum and CSF were intensively screened for bacterial and viral infections by using standard techniques (Table 2). No bacterial or viral pathogens, except HMPV, were detected. RNA of this virus was identified by reverse transcription (RT)–PCR in both brain and lung tissue specimens. Moreover, all tissue specimens were mounted routinely on different cell lines susceptible to viruses commonly known to cause encephalitis (Table 3), but HMPV RNA was detected by PCR only in the cell culture supernatant of a Vero culture mounted with lung tissue for 3 weeks. Although no cytopathic effect was observed in any of the cell cultures, the fluid from the Vero cells mounted with lung tissue was repeatedly positive for HMPV RNA. None of the other viruses was detected by PCR, and no cytopathic effect was seen in any of the cell cultures.
Amplified fragments of HMPV DNA derived from the Vero cell culture supernatant were subjected to direct sequencing. The alignment of the resulting sequences showed close relatedness of HMPV RNA sequences present in brain and lung tissues and those obtained from the supernatant of infected cell culture (Figure 2). Upon phylogenetic analysis, the identified HMPV sequences were clearly separated from the sequences of other HMPV isolates obtained by our laboratory (13). These results allowed us to exclude the possibility of contamination of the brain and lung tissues under investigation with HMPV sequences from another source.
Virologic data on the detection of HMPV were complemented by results of histologic and immunochemical investigations. Thus, both the lung and the brain tissues showed evidence of an active inflammation. The alveolar lumina were partly or completely filled with fluid mixed with inflammatory cells, and the alveolar walls were thickened. The alveoli in half of the specimens were atelectatic. Some bronchioles had segmental loss of epithelium; meninges were diffusely thickened by many neutrophils and a few macrophages mixed with fibrin and a few erythrocytes.
Unfortunately, specific immune staining of paraffin-embedded tissues did not allow us to detect HMPV antigens in the brain or lung of the patient. Several reasons may explain these negative results, including low concentration of viral antigens in the infected tissues, relatively low sensitivity of the immunochemical procedures, and a high sensitivity of the RT-PCR assay. Similar observations may be noted, namely, the positive RT-PCR findings of viral RNA and the inflammatory response in investigated tissues in the case of Nipah virus infection of the brain (11).
To our knowledge, this case report is the first of fatal encephalitis that might be associated with HMPV infection. We base a possible etiologic relationship between HMPV and the observed neurologic manifestations on the detection of HMPV RNA in the brain and lung tissues. Some clinical observations might serve as circumstantial evidence to support this hypothesis. The clinical course and MRI data for our patient are very similar to those observed in several patients with fatal encephalitis associated with Nipah virus infection, another member of the paramyxovirus family (8,11). Definite conclusions on the possible involvement of HMPV in neurologic disorders might be drawn only after additional studies. At this stage, however, we recommend HMPV screening for patients, especially young children, with symptoms of encephalitis of unknown origin. These investigations might extend our knowledge of the clinical manifestations and consequences of HMPV infection.
Dr. Schildgen received his PhD in molecular biology from the University of Essen. He is currently performing postdoctoral work on the epidemiology of human metapneumovirus, hepatitis B virus drug resistance, and human herpesvirus-1 DNA replication.
The authors are grateful to A. Osterhaus, Thijs Kuiken, and Debby van Riel for excellent histochemistry and critical comments on the manuscript.
Sergei Viazov was supported by a grant from the IFORES program of the Medical Faculty of the University of Essen.
- van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7:719–24.
- Bastien N, Ward D, Van Caeseele P, Brandt K, Lee SH, McNabb G, Human metapneumovirus infection in the Canadian population. J Clin Microbiol. 2003;41:4642–6.
- Biacchesi S, Skiadopoulos MH, Boivin G, Hanson CT, Murphy BR, Collins PL, Genetic diversity between human metapneumovirus subgroups. Virology. 2003;315:1–9.
- Peret TC, Boivin G, Li Y, Couillard M, Humphrey C, Osterhaus AD, Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis. 2002;185:1660–3.
- Viazov S, Ratjen F, Scheidhauer R, Fiedler M, Roggendorf M. High prevalence of human metapneumovirus infection in young children and genetic heterogeneity of the viral isolates. J Clin Microbiol. 2003;41:3043–5.
- van den Hoogen BG, Osterhaus DM, Fouchier RA. Clinical impact and diagnosis of human metapneumovirus infection. Pediatr Infect Dis J. 2004;23(Suppl):S25–32.
- Boivin G, De Serres G, Cote S, Gilca R, Abed Y, Rochette L, Human metapneumovirus infections in hospitalized children. Emerg Infect Dis. 2003;9:634–40.
- Chua KB, Goh KJ, Wong KT, Kamarulzaman A, Tan PS, Ksiazek TG, Fatal encephalitis due to Nipah virus among pig farmers in Malaysia. Lancet. 1999;354:1257–9.
- Gonzalez-Gil J, Zarrabeitia MT, Altuzarra E, Sanchez-Molina I, Calvet R. Hydrocephalus: a fatal late consequence of mumps encephalitis. J Forensic Sci. 2000;45:204–7.
- Hooper PT, Williamson MM. Hendra and Nipah virus infections. Vet Clin North Am Equine Pract. 2000;16:597–603.
- Paton NI, Leo YS, Zaki SR, Auchus AP, Lee KE, Ling AE, Outbreak of Nipah-virus infection among abattoir workers in Singapore. Lancet. 1999;354:1253–6.
- Schneider-Schaulies J, Meulen V, Schneider-Schaulies S. Measles infection of the central nervous system. J Neurovirol. 2003;9:247–52.
- Schildgen O, Geikowski T, Glatzel T, Simon A, Wilkesmann A, Roggendorf M, New variant of the human metapneumovirus (HMPV) associated with an acute and severe exacerbation of asthma bronchiale. J Clin Virol. 2004;31:283–8.
- Figure 1. . Axial T1-weighted magnetic resonance imaging (MRI) scan (A) and coronal fluid attenuated inversion recovery (FLAIR) (B) show multifocal, mainly cortical and subcortical lesions of high signal intensity, which...
- Figure 2. . Alignment of 302 nucleotide human metapneumovirus (HMPV) sequences amplified from brain and lung tissues of the patient and from the supernatant of infected Vero cell culture. Sequence of...
- Table 1. Overview of laboratory parameters tested before the patient was admitted to the primary care hospital
- Table 2. Virologic tests performed on patient specimens†
- Table 3. Cell lines routinely used for isolation of individual viral pathogens†
Please use the form below to submit correspondence to the authors or contact them at the following address:
Oliver Schildgen, University of Bonn, Institute for Medical Microbiology and Immunology, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany; fax: +(49)-(0)228-287-4433
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: April 25, 2012
- Page last updated: April 25, 2012
- Page last reviewed: April 25, 2012
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)